Logo

Covaris: Annemarie Watson

Aug 01, 2022

Annemarie Watson has been appointed as CEO of Covaris, effective immediately. She succeeds founder Jim Laugharn, who became chief technology officer and remains a company board member. Watson comes to Covaris from Eurofins Scientific, where she was senior VP of clinical diagnostics. Previously, she was president of Crane Currency, and before that, VP of business process improvement and global supply chain at MDS (now Nordion). She holds a bachelor of applied science degree in engineering and mathematics from Queen’s University in Ontario, Canada, and an MBA from Harvard Business School.

Breaking News
The Scan

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.

Neurological Outcomes Linked to Innate Immune Features After Cardiac Arrest

Researchers reporting in Med dig into immune features found a few hours after cardiac arrest that correspond with neurological outcomes.

Mouse Study Finds Circadian Rhythm-Related Gene Expression Changes Linked to Sleep Apnea

A paper in PLOS Biology reveals tissue-specific circadian rhythm and gene expression patterns in an intermittent hypoxia-based mouse model of obstructive sleep apnea.

Polygenic Risk Score to Predict Preeclampsia, Gestational Hypertension in Pregnant Women

Researchers in Nature Medicine provide new mechanistic insights into the development of hypertensive disorders of pregnancy, which may help develop therapeutics.